Instituto de Investigación Biomédica de Málaga (IBIMA) » A PHASE3, OPEN – LABEL LONG-TERM EXTENSION STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BMN111 IN CHILDREN WITH ACHONDROPLASIA_111-302

A PHASE3, OPEN – LABEL LONG-TERM EXTENSION STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BMN111 IN CHILDREN WITH ACHONDROPLASIA_111-302

14 agosto, 2019
/
0

0 Compartir

0 Compartir

Subscribe

Suscríbete a nuestro Newsletter y recibe en tu correo todas las últimas novedades del Instituto.

Enlaces

-->

Calle Doctor Miguel Díaz Recio , 28 Málaga 29010

(+34) 951 440 260
Fax: (+34) 951 440 263

info@ibima.eu
www.ibima.eu